A 1954 outbreak at a Boston boarding school allowed scientists to isolate the measles virus and formed the basis for the first measles vaccine.

Measles infection, which was nearly universal during childhood in prevaccine era, was described by the Persian physician Rhazes in the 10th century as "more to be dreaded than smallpox."

The measles vaccine has saved an estimated 94 million lives since its introduction.

Explore a technical look at the measles virus and its toll on humanity through the ages.

Measles was declared eliminated in the US in 2000, meaning the country had been free of continuous disease transmission for 12 months or more.

Measles evolved from an ancient cattle disease, branching off as recently as 3,000 years ago.

Measles cases in the US reached a 35-year high in 2026 as vaccination rates dropped.

Measles attacks the body's immune system, leaving it vulnerable to secondary complications.

Measles is one of the most contagious preventable diseases—it was eliminated in the US in 2000, but it is now making a resurgence due to declining vaccination rates.

What is the measles, mumps, and rubella vaccine?

Federal guidance currently recommends a two-shot schedule of the MMR vaccine for children in most cases, once at 12 to 15 months and once at 4 to 6 years. (A September 2025 update only called for the elimination of a combined vaccine that included protection against varicella, the MMRV shot.)

Before vaccines, there was 'variolation': what was it?

Before the technology behind vaccinations was discovered, some keen observers of medicine around the globe noticed how previous infections could impact future ones. Learn about the techniques early physicians used before they had vaccines.

A look at the 2025 measles outbreak in West Texas and surrounding areas

A measles outbreak in the summer of 2025 ultimately led to more than 900 cases and the deaths of two young children. The highly contagious virus requires vaccination rates near 95% to achieve herd immunity—the Texas outbreak spread through areas of significant mistrust of vaccines, including the area’s Mennonite community.

Discover the latest information on US measles cases from official outbreak tracking figures.

A rare measles complication is that the virus can linger in the body for years after apparent recovery and continue to replicate—leading to a progressive and fatal breakdown of the central nervous system that can occur decades after the initial infection.

Diphtheria was once a leading childhood killer before antibiotics and vaccines

In 18th- and 19th-century outbreaks, some New England families lost as many as eight children to diphtheria, and fatality rates in hospitals often topped 60%. The invention of antitoxins, penicillin, and vaccines dramatically reduced deaths.

Jonas Salk developed the first successful polio vaccine—and tested it on himself

The American medical researcher developed the inactivated virus vaccine from 1952 to 1955 and proved that it could prevent disease. He tested the virus on himself and his family in 1954 and then carried out formal clinical trials on more than 1.3 million children.

Measles reached global transmission during the 15th- and 16th-century Columbian exchange

Devastating diseases like smallpox, influenza, measles, and other viruses were largely introduced into the Western Hemisphere beginning with the 1492 arrival of Christopher Columbus and the ensuing age of exploration.

Edward Jenner, the father of vaccinations

The British physician was the first to attempt to inoculate someone from smallpox using its milder cousin, cowpox. His innovations and documentations would prove crucial to the deployment of widespread vaccinations.

A major US-designed polio vaccine was first tested in the Soviet Union

Albert Sabin's live attenuated virus vaccine—requiring two drops in the mouth—didn't garner political support in the US, so it was tested in the Soviet Union in the late 1950s.

Live virus vaccines predated polio—that's how we vaccinate against smallpox

Since 1796, smallpox vaccines have used a live poxvirus related to smallpox. Yellow fever vaccines have used a live weakened form of the virus responsible for yellow fever since 1937.

Vitamin A does not cure measles, but it helps reduce the symptoms

Also known as retinol, vitamin A plays a significant role in supporting the body’s immune system. The virus attacks the immune system, and studies have shown a correlation between vitamin deficiency and severity of measles symptoms. Supplemental vitamin A doses are now a part of recommended treatment for pediatric patients.

Measles infection can cause long-term immune system “amnesia”

The measles virus attacks the body's immune system, including preying on T and B cells in the lymphatic system. These cells hold memories of past infections, which can be degraded as the virus destroys them. This leaves patients susceptible to other infections for a year or longer.

Secondary complications from measles in children range across the whole body.

An Ebola vaccine was developed during the 2018 west African Ebola outbreak, but the 2026 Ebola outbreak is with a different species of the virus, not the one that the vaccine is approved to treat.

HFMD was first reported in 1957 in New Zealand

The first clinical report involved eight kids with the characteristic sores in New Zealand, and then in the years that followed there were dozens more cases there and also reports of outbreaks in England and Scotland, among other settings, including the US.

Attenuated vaccines introduce a weakened version of the virus into the body

Some vaccines, like those for measles, rely on weakened versions of a virus. These weakened pathogens are introduced into the body, triggering an immune response and helping the immune system learn to protect itself against stronger versions of the virus. (This also explains why some vaccines make you feel under the weather.)

A scientist successfully treated her own breast cancer by injecting the tumor with lab-grown viruses.

The flu vaccine has evolved alongside discoveries of new virus strains

After influenza B was identified in 1940, researchers created a two-strain vaccine by 1942. The WHO later built a global surveillance system to track mutations, enabling vaccines to be updated annually to target the strains most likely to circulate.

Measles symptoms range from fever to pneumonia and encephalitis

While less common, most measles-related deaths come from secondary conditions such as pneumonia (one to six cases per 100 patients) and encephalitis (one case per 1,000 patients). Blindness, which is rare, may arise from corneal ulceration.

In 1933, the influenza virus was first identified through 'ferret flu' experiments, which proved that the disease was viral—not bacterial.

The 2026 Ebola outbreak in the DRC is spurring new Ebola vaccine development for the Bundibugyo species.

Variola: the second-deadliest virus on Earth

Because it was declared eradicated in 1980, many forget smallpox is one of history's deadliest diseases—in its final century, it's estimated to have claimed 500 million lives. This 11-minute video from production studio Kurzgesagt takes a look at...

How the 1918 pandemic spurred developments in virology and vaccines

This article provides an in-depth historical account of the 1918 Spanish Flu pandemic, including its impact on the global population and how its occurrence spurred significant advancements in the study of viruses—laying the groundwork for the...

See the evolution of Ebola vaccine and treatment development.

Improved 19th-century sanitation meant kids encountered polio later, with worse results

Almost all children likely used to contract poliovirus, but scientists suggest that when infants encountered it very early in life—due to poorer conditions and hygiene—they still had some maternal protection from pregnancy or through breastmilk, so the symptoms were more flu-like.

Two Lyme disease vaccines were in development in 2026

As of early 2026, there was no vaccine for Lyme disease available. One candidate vaccine, VLA15, was in later-stage clinical trials. Another designed to provide seasonal protection was licensed to a pharmaceutical company in 2025, and was planned for human clinical trials.

Malaria vaccines are not routine because they have limited effectiveness.

Using mosquitoes to vaccinate bats could curb the spread of deadly diseases.

There are two recommended malaria vaccines by world health experts, but both have limited effectiveness.

The oral, live virus vaccine is the most robust but carries more risks

The live virus vaccine, delivered via oral drops, induces the best protection in the body. Because it includes a live, weakened form of the virus there's an extremely small risk it can sicken recipients and potentially cause paralysis. Recipients also shed the virus in their stool, which can rarely lead to vaccine-derived cases of the virus if the virus mutates. (Some users may experience a paywall.)

Wastewater testing has detected genetic evidence of polio, triggering vaccine boosters

Sampling of wastewater in London in 2022 detected fragments of polio virus, suggesting a vaccine-derived version of polio may be circulating. No one became ill, but the finding did trigger calls for a renewed booster inoculation campaign.

Oral polio vaccines cause approximately 250 to 500 polio cases per year globally

Live, weakened polioviruses in the oral vaccine can very rarely mutate into a disease-causing form and lead to vaccine-associated paralytic poliomyelitis. This oral vaccine is not available in the United States.

The virus was officially described for the first time in 1789

Michael Underwood, an English physician and surgeon, was the first to describe the disorder, noting it caused disability in the lower extremities in children. Large-scale outbreaks of the disease were not observed until the late 19th century.

Most polio cases today are vaccine-derived rather than naturally occuring

Weakened, live virus vaccines—which aren't offered in the US—carry a risk of virus being shed in the stool. Rarely, the shed virus mutates and leads to vaccine-derived polio infections. Most recent polio cases are genetically linked to those vaccines. As shown in this graphic, there are typically hundreds of vaccine-derived polio cases annually.

A heatmap showing the drop in infectious diseases post-vaccine deployment

The number of infected people, measured over 70-some years and across all 50 states and the District of Columbia, declined significantly after vaccines were introduced.

Breaking down the different types of vaccine technologies

There are several different types of vaccines. Each type is designed to teach your immune system how to fight off germs—and the serious diseases they cause. This short overview breaks down the differences between the types.

A history of vaccine rollouts

History tells us the public will tolerate risk of harm from a vaccine if their fear of the disease exceeds their fear of the vaccine.

The US military, concerned about potential deployments worldwide, has long funded experimental hantavirus vaccines and therapies.

Collaborations between the military, biotech, and academic researchers led to an experimental antibody treatment for the Andes hantavirus strain—the one that more readily passes between humans. As of spring 2026, it had only been tested in animals. The US Army has also tested a potential hantavirus vaccine in people. It published early findings in 2023 that seemed promising, eliciting some immune system response. (Some users may encounter a paywall.)

What are universal vaccines?

As viruses mutate and develop, vaccines have to adapt, leading to regular recommended injections like flu shots. Researchers are working to develop universal vaccines that aim to protect against multiple virus variants if not entire virus families. These vaccines work by creating broadly neutralizing antibodies (bnAbs) that target aspects of viruses that don't typically mutate and are integral to the virus' survival.

Environmental conditions, shifting immunity, and viral strain could help explain 2025 spike

The surge in HFMD in the summer and early fall of 2025 in the mid-Atlantic could be the result of a confluence of factors, including a more virulent strain of disease-causing virus, good environmental conditions for the virus to spread—hot, humd—and a potential immunity gap among kids due to milder HFMD outbreaks the previous year.

Henrietta Lacks' tumor cells became the first recognized 'immortal' cell line about 75 years ago, but researchers are still investigating the specific mechanisms that enabled the cells to continuously grow and divide in the laboratory.